RPG Life Sciences Limited (NSE:RPGLIFE)
2,636.60
-18.20 (-0.69%)
Aug 21, 2026, 3:29 PM IST
RPG Life Sciences Market Cap
RPG Life Sciences has a market cap or net worth of 43.61 billion as of August 21, 2026. Its market cap has increased by 12.50% in one year.
Market Cap
43.61B
Enterprise Value
41.06B
Revenue
7.34B
Ranking
n/a
PE Ratio
36.45
Stock Price
2,636.60
ChartMarket Cap Chart
Since June 10, 2008, RPG Life Sciences's market cap has increased from 645.16M to 43.61B, an increase of 6,659.05%. That is a compound annual growth rate of 26.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 43.61B | 13.53% |
| Dec 31, 2025 | 38.41B | 6.31% |
| Dec 31, 2024 | 36.13B | 63.53% |
| Dec 29, 2023 | 22.09B | 57.71% |
| Dec 30, 2022 | 14.01B | 37.00% |
| Dec 31, 2021 | 10.23B | 67.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Strides Pharma Science | 88.26B |
| Aarti Pharmalabs | 75.62B |
| Sun Pharma Advanced Research Company | 62.67B |
| Innova Captab | 62.04B |
| Orchid Pharma | 49.71B |
| Ind-Swift Laboratories | 29.00B |
| Solara Active Pharma Sciences | 26.50B |
| Beta Drugs | 24.22B |